Latest Janssen-Cilag International NV Stories
BEERSE, Belgium, February 19, 2010 /PRNewswire-FirstCall/ -- - Cilag GmbH International to Terminate Collaboration Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a negative opinion on its Marketing Authorisation Application (MAA) for the antibiotic ZEFTERA(TM) (ceftobiprole medocaril), for the treatment of complicated skin and soft tissue infections. Cilag GmbH...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.